Rani Therapeutics Holdings Inc To discuss the results from its Phase 1 clinical trial of RT-111. Transcript
Welcome to the Lannett therapeutics RT. one 11 Phase one study Top Line Results Conference Call.(Operator Instructions) As a reminder, this call is being recorded today, Monday, February fifth, 2024.
I would now like to turn the conference call over to Lawrence Watts, Managing Director at Gilmartin Group. Please go ahead.
Thank you, operator. Joining us on the call today from Ronnie therapeutics, our Chief Executive Officer, to let them run out and develop VP of Clinical Development and Chief Financial Officer Space Center.
Please turn to Slide 2. During this conference call, management will make forward-looking statements that are subject to risks and uncertainties related to future events and financial performance of the Company. These forward-looking statements are subject to a number of risks, uncertainties and assumptions such as but not limited to, those discussed in the Risk Factors section of the Company's filings with the Securities and Exchange Commission, including its annual report on Form 10 K
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
